MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Sonoma Pharmaceuticals Total Inventories 2011-2026 | SNOA
Annual Total Inventories Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.92 M | 2.72 M | 2.86 M | 2.66 M | 2.53 M | 2.19 M | 3.41 M | 2.86 M | 2.22 M | 1.64 M | 1.4 M | 1.09 M | 992 K | 953 K | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.41 M | 953 K | 2.17 M |
Quarterly Total Inventories Sonoma Pharmaceuticals
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.63 M | 3.8 M | 2.92 M | 3.14 M | 2.84 M | 2.66 M | 2.72 M | 2.96 M | 2.51 M | 2.73 M | 2.86 M | 2.85 M | 3.02 M | 2.79 M | 2.66 M | 2.88 M | 2.48 M | 2.62 M | 2.53 M | 2.96 M | 3.7 M | 4.19 M | 4.19 M | 2.82 M | 3.1 M | 3.37 M | 3.41 M | 3.22 M | 2.95 M | 2.6 M | 2.86 M | 2.7 M | 2.6 M | 2.38 M | 2.22 M | 2.07 M | 2.08 M | 1.99 M | 1.6 M | 1.61 M | 1.67 M | 1.47 M | 1.4 M | 1.35 M | 1.24 M | 1.31 M | 1.09 M | 970 K | 749 K | 813 K | 992 K | 901 K | 876 K | 818 K | 953 K | 1.02 M | 887 K | 762 K | 733 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 4.19 M | 733 K | 2.26 M |
Total Inventories of other stocks in the Drug manufacturers industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alimera Sciences
ALIM
|
1.88 M | - | - | $ 142 M |  USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
1.24 M | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
40.4 M | - | - | $ 754 M | USA |
 |
Canopy Growth Corporation
CGC
|
96.4 M | $ 1.2 | 1.27 % | $ 129 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
1.11 M | - | 7.5 % | $ 6.35 M | USA |
 |
Agile Therapeutics
AGRX
|
2.74 M | - | 10.11 % | $ 58.2 M | USA |
 |
Catalent
CTLT
|
574 M | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
2.22 M | - | - | $ 50.1 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
47.8 M | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
246 M | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
482 K | - | - | $ 36.6 M | USA |
 |
Emergent BioSolutions
EBS
|
329 M | $ 13.92 | 5.86 % | $ 713 M | USA |
 |
Athenex
ATNX
|
42.7 M | - | -23.39 % | $ 1.76 M | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
20.3 M | $ 21.48 | -0.12 % | $ 2.04 B |  France |
 |
Evolus
EOLS
|
12.2 M | $ 5.72 | -3.3 % | $ 355 M | USA |
 |
Harrow Health
HROW
|
10.9 M | $ 50.79 | -5.07 % | $ 1.66 B | USA |
 |
China Pharma Holdings
CPHI
|
2.27 M | $ 1.38 | 9.13 % | $ 24.1 M |  China |
 |
Jupiter Wellness
JUPW
|
234 K | - | - | $ 33.6 M | USA |
 |
Bausch Health Companies
BHC
|
1.54 B | $ 7.9 | 3.41 % | $ 2.88 B | Canada |
 |
Lannett Company
LCI
|
95.2 M | - | 1.15 % | $ 7.11 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
4 M | $ 5.14 | 8.9 % | $ 72.3 M | USA |
 |
Organogenesis Holdings
ORGO
|
26.2 M | $ 4.32 | -0.92 % | $ 569 M | USA |
 |
Pacira BioSciences
PCRX
|
125 M | $ 26.13 | 3.24 % | $ 1.21 B | USA |
 |
PetIQ
PETQ
|
159 M | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
10.3 M | - | -4.76 % | $ 65.3 M | USA |
 |
Perrigo Company plc
PRGO
|
1.08 B | $ 14.7 | -0.47 % | $ 2.02 B | USA |
 |
ProPhase Labs
PRPH
|
3.98 M | - | - | $ 5.07 M | USA |
 |
Rockwell Medical
RMTI
|
5.87 M | $ 0.95 | 2.85 % | $ 22.2 M | USA |
 |
Radius Health
RDUS
|
11.4 M | - | - | $ 1.42 B | USA |
 |
OptiNose
OPTN
|
8.05 M | - | - | $ 1.08 B | USA |
 |
Assertio Holdings
ASRT
|
37.7 M | $ 9.35 | -1.86 % | $ 664 M | USA |
 |
PLx Pharma
PLXP
|
2.46 M | - | -27.8 % | $ 2.56 M | USA |
 |
SCYNEXIS
SCYX
|
899 K | $ 0.64 | -0.12 % | $ 30.6 M | USA |
 |
Tilray
TLRY
|
201 M | $ 8.95 | -3.35 % | $ 5.53 B | Canada |
 |
Veru
VERU
|
4.14 M | $ 2.34 | 0.43 % | $ 316 M | USA |
 |
TherapeuticsMD
TXMD
|
7.99 M | $ 2.0 | -2.0 % | $ 20.9 M | USA |
 |
Viatris
VTRS
|
3.52 B | $ 12.42 | 0.12 % | $ 15.1 B | USA |
 |
cbdMD
YCBD
|
2.52 M | $ 1.11 | -3.91 % | $ 4.79 M | USA |
 |
Zomedica Corp.
ZOM
|
5.12 M | - | -0.21 % | $ 98 M | USA |